SPL 3.00% 9.7¢ starpharma holdings limited

AGM Notes, page-37

  1. 15,657 Posts.
    lightbulb Created with Sketch. 5718
    Yep ... that was the words she used

    @Analysta said same thing:

    Slide 28 - Dendrimer Enhanced Products (DEP) Dual Strategy
    They have a dual strategy internal and a partnered program. They have the AZ multiproduct licence and 2 under development. AZD0455 for USD126m + royalties. The first estimate was for over $1bn peak sales and now that has become a multi-billion estimate for this one single product. JF stated that "the performance of AZD0455 is quite remarkable".
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.